Regeneron antibody drug appears effective at preventing COVID
US biotech firm Regeneron and its Swiss partner Roche unveiled promising clinical trial results Monday indicating that an antibody treatment
Read moreUS biotech firm Regeneron and its Swiss partner Roche unveiled promising clinical trial results Monday indicating that an antibody treatment
Read moreThere’s widespread agreement that it’s important to help older adults and people with disabilities remain independent as long as possible.
Read moreDecontamination chambers, tight-fitting protective suits, a controlled atmosphere: vigilance is the order of the day when making COVID-19 vaccines at
Read moreTomorrow is National Dogfighting Awareness Day, so today we want to give you an inside look on what it’s like
Read moreA Scientific E-Poster to be presented at the 2021 ARRS Virtual Annual Meeting found the COVID-19 “Safer at Home” order
Read moreAt least 11 states will open vaccine eligibility to all adults this week in a major expansion of COVID-19 shots
Read moreOnly 3% of patients at high risk for primary aldosteronism (PA), a common disorder that causes high blood pressure and
Read moreWhen she was 12, Jennifer Tripucka was so embarrassed by the scar that runs from the middle of her stomach
Read moreNew research is shedding light on how dementia can increase people’s risk for developing COVID-19, particularly among two groups: African
Read moreNearly a THIRD of Covid ‘long-haulers’ had NO symptoms when they tested positive – but were still suffering fatigue and
Read more